Skip to main content

Northwestern Startup: Syenex, Inc.

For licensing information, contact:
Startup Available for Partnership,

Northwestern Inventor:
Joshua Leonard
McCormick School of Engineering
Chemical and Biological Engineering

Syenex builds bioengineering technologies to unlock the future of human health. Leveraging the power of synthetic biology, we design scalable, precision-engineered components, empowering cell and gene therapy developers to cure disease and build the next generation of medicines. Designed to break the barriers that slow medical progress, our Open Science model ensures global access to our expanding toolkit and network of scale-up partners, accelerating the path of breakthroughs from idea to impact for all of academia and biopharma. Since 2022, Syenex has rapidly built a portfolio of cell-specific bioengineering system and established partnerships across the fields of immune cell, stem cell, and hepatocyte engineering.

Patent Information:
Categories:

Life Sciences > Biomarkers & Biomedical Research Tools

Life Sciences > Therapeutics

Keywords:

Biologic
Biomedical
Drug delivery
Gene therapy
Platform technology
Research tool
Startup with Northwestern IP
Synthetic biology
Therapeutics
Vector/Plasmid